These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 17869492)
1. Is there a limit to dose escalation for rectal cancer? Cummings BJ Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):730-7. PubMed ID: 17869492 [TBL] [Abstract][Full Text] [Related]
2. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy. Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445 [TBL] [Abstract][Full Text] [Related]
3. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment. Gauthier I; Carrier JF; Béliveau-Nadeau D; Fortin B; Taussky D Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1128-33. PubMed ID: 19147306 [TBL] [Abstract][Full Text] [Related]
4. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data. Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683 [TBL] [Abstract][Full Text] [Related]
5. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer. O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021 [TBL] [Abstract][Full Text] [Related]
7. Dose escalated external beam radiotherapy versus neoadjuvant androgen deprivation therapy and conventional dose external beam radiotherapy for clinically localized prostate cancer: do we need both? Roach M Strahlenther Onkol; 2007 Dec; 183 Spec No 2():26-8. PubMed ID: 18167004 [TBL] [Abstract][Full Text] [Related]
8. The need and prospect of individualized external beam radiotherapy dose escalation beyond 80 gy to treat prostate cancer: in regard to Eade et al. (Int J. Radiat. Oncol. Biol. Phys. 2007;68:682-689). Cheung MR Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207039 [No Abstract] [Full Text] [Related]
9. Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer. Chan LW; Xia P; Gottschalk AR; Akazawa M; Scala M; Pickett B; Hsu IC; Speight J; Roach M Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):69-77. PubMed ID: 18342454 [TBL] [Abstract][Full Text] [Related]
10. [Intraoperative radiotherapy]. Hata K; Miyoshi M; Uehara S; Shimamura Y; Furusawa M; Tomoda H; Seo Y; Abe M; Hara Y; Jimi S Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1564-9. PubMed ID: 3592700 [TBL] [Abstract][Full Text] [Related]
12. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer. van der Laan HP; van den Bergh A; Schilstra C; Vlasman R; Meertens H; Langendijk JA Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1138-45. PubMed ID: 17931794 [TBL] [Abstract][Full Text] [Related]
13. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Georg P; Kirisits C; Goldner G; Dörr W; Hammer J; Pötzi R; Berger D; Dimopoulos J; Georg D; Pötter R Radiother Oncol; 2009 May; 91(2):173-80. PubMed ID: 19243846 [TBL] [Abstract][Full Text] [Related]
14. Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique: analysis of 542 consecutive patients. Jereczek-Fossa BA; Vavassori A; Fodor C; Santoro L; Zerini D; Cattani F; Garibaldi C; Cambria R; Fodor A; Boboc GI; Vitolo V; Ivaldi GB; Musi G; de Cobelli O; Orecchia R Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):784-94. PubMed ID: 18191332 [TBL] [Abstract][Full Text] [Related]
15. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Fuller DB; Naitoh J; Lee C; Hardy S; Jin H Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1588-97. PubMed ID: 18374232 [TBL] [Abstract][Full Text] [Related]
16. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience. Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396 [TBL] [Abstract][Full Text] [Related]
17. Rectal dose reduction using three-dimensional conformal radiotherapy for locally advanced prostate cancer: A combination of conformal dynamic-arc and five-static field technique. Sasaoka M; Nishikawa A; Futami T; Nishida K; Miwa H; Kadoya K Radiother Oncol; 2009 Mar; 90(3):318-24. PubMed ID: 19008004 [TBL] [Abstract][Full Text] [Related]
18. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. Nieder AM; Porter MP; Soloway MS J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517 [TBL] [Abstract][Full Text] [Related]
19. Effect of high-dose-rate 192Ir source activity on late rectal bleeding after intracavitary radiation therapy for uterine cervix cancer. Suzuki O; Yoshioka Y; Isohashi F; Morimoto M; Kotsuma T; Kawaguchi Y; Konishi K; Nakamura S; Shiomi H; Inoue T Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1329-34. PubMed ID: 18439763 [TBL] [Abstract][Full Text] [Related]
20. External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis. Hoffman KE; Hong TS; Zietman AL; Russell AH Cancer; 2008 Feb; 112(4):943-9. PubMed ID: 18098220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]